DIBIASE MARY (Chief Operating Officer) received a stock award from X4 PHARMACEUTICALS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/14/2025ACC: 0001628280-25-005696
Officer· Chief Operating Officer
Since Sep 2021
+650K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
650K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+650K
Price / share
—
Trade value
—
% of position
132.4%
2/12/2025
490.98K→1.14M
Total
Net shares
+650K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2025 | A · Award | +650K | — | — | 132.4% | 490.98K | 1.14M |
| Total | +650K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported